Münster / Leverkusen, 25th February 2016: Today launched the implementation of a new concept for TV coverage. Biofrontera AG, Leverkusen is the first company with which this innovative concept will be implemented. Biofrontera AG is specialised in the development of new medicines and medical cosmetics.
Within the TV interviews Mr Schaffer, CFO of Biofrontera, speaks on current corporate developments. Specifically, Mr. Schaffer gives an overview of the state of the current approval process in the United States as well as the estimated market potential. Another aspect of the interview is the indication expansion on the basal cell carcinoma. Finally he gives an overview of the current funding situation.
The interview was recorded in German and English and is available on the platform www.sri2capital.de.